Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
By How Much Is The Hypertrophic And Keloid Scar Treatment Market Expected To Expand Between 2025 And 2029?
The hypertrophic and keloid scar treatment market has shown significant expansion in recent years. It is anticipated to increase from $7.72 billion in 2024 to $8.49 billion in 2025, achieving a compound annual growth rate (CAGR) of 10.0%. This past growth can be attributed to the increasing occurrence of hypertrophic and keloid scars, developments in scar assessment, the broad usage of topical treatments, surgical and invasive procedures, and patient desire for improved scar appearance.
The hypertrophic and keloid scar treatment market size is projected to experience swift expansion over the coming years. This market is anticipated to reach “$12.46 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 10.1%. The expansion during this projection period can be attributed to several factors, including the emergence of minimally invasive procedures, improvements in scar revision methodologies, increased enthusiasm for combination treatments, a rise in awareness leading to earlier intervention, and worldwide aesthetic movements. Key developments expected during the forecast period encompass novel injectable treatments, multi-modal therapies designed for enhanced synergistic outcomes, strategies focused on individual patient needs, innovative technologies for scar evaluation, and the utilization of telemedicine for ongoing care and appointments.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10692&type=smp
Which Factors And Drivers Are Influencing The Hypertrophic And Keloid Scar Treatment Market In 2025?
The hypertrophic and keloid scar treatment market is anticipated to expand due to a rise in road accidents and burn incidents. Road accidents are defined as occurrences on roads involving at least one vehicle and individuals. Both road accidents and burn cases demand careful attention and suitable actions for prevention and effective care. Hypertrophic and keloid scar treatments are applied to individuals injured in road accidents, helping to reduce the height and tightness of scars. The growing frequency of road accidents and burn cases fuels the expansion of the hypertrophic and keloid scar treatment market. For example, data from August 2022, provided by the National Highway Traffic Safety Administration, a US-based federal government agency under the Department of Transportation, revealed that in the first three months of 2022, approximately 9,560 persons died in motor vehicle traffic accidents, representing an increase of nearly 7% when contrasted with the 8,935 fatalities during the identical period in 2021. Additionally, the mortality rate climbed from the estimated 1.25 fatalities per 100 million vehicle miles in the first quarter of 2021 to 1.27 fatalities per 100 million vehicle miles in the first quarter of 2022. Consequently, the rising number of road accidents and burn cases will propel the hypertrophic and keloid scar treatment market.
What Are The Leading Segments Analyzed In The Hypertrophic And Keloid Scar Treatment Market?
The hypertrophic and keloid scar treatmentmarket covered in this report is segmented –
1) By Treatment: Cryotherapy; Surgical Excision; Pressure Dressings; Intralesional 5-Fluorouracil; Superficial X-Ray; Intralesional Corticosteroid Injection; Other Treatments
2) By Products: Topical Products; Laser Products; Injectables; Other Products
3) By Scar: Hypertrophic Scars; Keloid Scars
4) By End-Use: Hospitals; Clinics; Other End-Users
Subsegments:
1) By Cryotherapy: Liquid Nitrogen Cryotherapy; Intralesional Cryotherapy
2) By Surgical Excision: Simple Excision; Excision With Skin Grafting
3) By Pressure Dressings: Elastic Bandage Pressure Dressings; Silicone Gel Pressure Dressings
4) By Intralesional 5-Fluorouracil: Standalone 5-FU Treatment; Combination With Corticosteroids
5) By Superficial X-Ray: Low-Dose X-Ray Therapy; Combination X-Ray With Other Treatments
6) By Intralesional Corticosteroid Injection: Triamcinolone Acetonide Injection; Combination With 5-Fluorouracil
7) By Other Treatments: Laser Therapy; Radiotherapy; Interferon Therapy
Which Key Trends Are Expected To Influence The Hypertrophic And Keloid Scar Treatment Market In The Coming Years?
Leading companies in the hypertrophic and keloid scar treatment market are concentrating on developing clinically proven silicon-based solutions, such as medical-grade silicone strips, to maximize their profits. These medical-grade silicone strips are therapeutic products crafted from high-quality silicone material, specifically formulated to encourage scar healing and reduction. For example, in April 2023, Scar Erase, a UK-based company offering silicone-based scar reduction therapy, introduced Scar Erase silicone strips, a clinically tested and affordable option for scar recovery. Made from 3mm of medical-grade silicone, these strips assist in treating various types of scars, including hypertrophic, keloid, post-surgery, and stretch marks. This silicone technology encloses the scar area, promoting hydration and an ideal healing environment, which leads to significant improvements in scar texture, color, and height. The product is designed for comfort and discretion, providing an accessible at-home treatment solution for scars.
Which Key Market Players Are Investing In Expansion And Innovation Of Hypertrophic And Keloid Scar Treatment Market?
Major companies operating in the hypertrophic and keloid scar treatment market include Smith & Nephew plc, Merz Pharmaceutical LLC, Lumenis Ltd., Enaltus LLC, Sonoma Pharmaceuticals Inc., Molnlycke Health Care AB, Suneva Medical Inc., Pacific World Corporation, Perrigo Company plc, Cynosure Inc., Alliance Pharma plc, Newmedical Technology Inc., HRA Pharma, Scar Heal Inc., McKesson Medical Surgical Inc., Johnson & Johnson Private Limited, Medtronic plc, 3M Company, Sinclair Pharma plc, Avita Medical, Stratpharma AG, Revitol Corporation Inc., Scarfade, Biodermis, Mederma, Silagen
Download The Full Report For Exclusive Market Findings:
How Does The Hypertrophic And Keloid Scar Treatment Market Perform Across Key Geographic Regions?
North America was the largest region in the hypertrophic and keloid scar treatment market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global hypertrophic and keloid scar treatment market report during the forecast period. The regions covered in the hypertrophic and keloid scar treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Request A Customized Version Of The Hypertrophic And Keloid Scar Treatment Market Report:
https://www.thebusinessresearchcompany.com/customise?id=10692&type=smp
Browse Through More Reports Similar to the Global Hypertrophic And Keloid Scar Treatment Market 2025, By The Business Research Company
Dental Diagnostic Imaging Devices And Equipment Global Market Report 2025
Diagnostic And Monitoring Ophthalmic Devices And Equipment Market 2025
Magnetic Resonance Imaging Devices And Equipment Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model